Neuberger Berman Group’s bluebird bio BLUE Stock Holding History

Neuberger Berman Group’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-556	Closed	-$1.05M	–	1587
2018 Q3	$1.05M	Buy	556 +77	+16%	+$159K	﹤0.01%	1176
2018 Q2	$974K	Buy	479 +114	+31%	+$260K	﹤0.01%	1239
2018 Q1	$808K	Sell	365 -7,846	-96%	-$20M	﹤0.01%	1246
2017 Q4	$18.9M	Buy	+8,211	New	+$16.7M	0.02%	638
2017 Q1	–	Sell	-795	Closed	-$636K	–	1590
2016 Q4	$636K	Sell	795 -193	-20%	-$153K	﹤0.01%	1239
2016 Q3	$868K	Buy	+988	New	+$716K	﹤0.01%	1135
2016 Q2	–	Sell	-679	Closed	-$374K	–	1539
2016 Q1	$374K	Buy	+679	New	+$417K	﹤0.01%	1321
2015 Q3	–	Sell	-479	Closed	-$1.04M	–	1533
2015 Q2	$1.04M	Buy	479 +116	+32%	+$236K	﹤0.01%	1201
2015 Q1	$568K	Sell	363 -116	-24%	-$153K	﹤0.01%	1314
2014 Q4	$568K	Buy	+479	New	+$320K	﹤0.01%	1328

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group's BLUE Position: Q4 2018 in Review

Neuberger Berman Group sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 556 shares — an estimated $1.05M sold.

Neuberger Berman Group first reported a position in BLUE in Q4 2014 and held it in 10 quarters. The position peaked at $18.9M in Q4 2017. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

Neuberger Berman Group reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
Neuberger Berman Group sold 556 bluebird bio shares in Q4 2018, an estimated $1.05M.
Neuberger Berman Group first reported a position in bluebird bio in Q4 2014 and held it in 10 quarters.
Neuberger Berman Group's bluebird bio position peaked at $18.9M in Q4 2017.
251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Neuberger Berman Group's 13F filing for Q4 2018, filed 12 Feb 2019.